Efficacy of CPAP and NIV in long term treatment of OHS: the results of the Spanish multicentre randomised trial "Pickwicks" Source: International Congress 2015 – Sleep-disordered breathing Year: 2015
Short term treatment response in pulmonary sarcoidosis – a prospective study Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
Monitoring physical activity in COPD patients – a monocentric, prospective cohort study Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018 Year: 2018
RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021
Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017
Interim results for INSPIRE-CF: A 24-month RCT evaluating effects of weekly supervised exercise in children with CF Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Short Physical Performance Battery and long term prognosis following severe acute exacerbation of COPD: a prospective cohort study Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Predictors of weaning from helmet CPAP in COVID-19: preliminary results from a retrospective observational study Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond Year: 2021
Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Impact of cough on quality of sleep and effect of anti-tussive treatment in children: An observational study Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011
Impact of nivolumab-induced fever on the treatment effect: a retrospective study Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study Source: Eur Respir J, 59 (2) 2101341; 10.1183/13993003.01341-2021 Year: 2022
Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study. Source: Virtual Congress 2021 – Respiratory infections Year: 2021
Patient-reported outcome measures after COVID-19: a prospective cohort study Source: Eur Respir J, 56 (5) 2003276; 10.1183/13993003.03276-2020 Year: 2020
Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study Source: ERJ Open Res, 7 (3) 00243-2021; 10.1183/23120541.00243-2021 Year: 2021
Open label case-control study to assess Pidotimod efficacy in Non CF Bronchiectasis Disease: a pilot study Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019